# Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

> **NCT03241888** · PHASE2,PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 180 (actual)

## Conditions studied

- Atypical Endometrial Hyperplasia

## Interventions

- **DRUG:** Megestrol Acetate
- **DEVICE:** Levonorgestrel-releasing Intrauterine System(LNG-IUS)

## Key facts

- **NCT ID:** NCT03241888
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-04
- **Primary completion:** 2020-06-18
- **Final completion:** 2020-06-18
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03241888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03241888, "Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03241888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*